Testing effectiveness (Phase 2)Ended earlyNCT02124902
What this trial is testing
Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
Who this might be right for
Triple Negative Breast Neoplasms
Washington University School of Medicine 148